
265: Novavax's CEO promises a turnaround & how Lilly roiled the obesity market
The Readout Loud
00:00
Pfizer's Discontinuation of Trials of Small Molecule Pills
Pfizer's process is apparently getting a little more complicated in this field than maybe was initially thought. Some people see it as kind of setting back Pfizer in this race to develop oral products for obesity. So it seems like especially compared with Lillie Pfizer is falling behind and Lillie is really emerging as getting ahead in, especially in the race to developed oral products.
Transcript
Play full episode